Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
Testing for C. diff starts with a stool sample you provide to a clinician, who orders lab tests such as a PCR (NAAT) test for toxin genes, a toxin A/B EIA, or a two-step algorithm that combines a GDH antigen test with toxin detection. Most labs only accept loose or watery stool, so a sample that takes the shape of the container is usually required, and testing is generally reserved for people with three or more unformed stools in 24 hours, recent antibiotic use, or recent hospitalization. Stool appearance alone cannot confirm the diagnosis, and features like foul odor, greenish color, mucus, or visible blood can point to other causes that change which tests you need. There are several important factors that affect whether you qualify for testing, how fast you should be seen, and which warning signs mean urgent care, so see below for the complete details before deciding your next step.
Because the path to a C. diff test depends on your specific symptom pattern, recent medications, and risk factors, a free, instant, online symptom check can help you organize what you are experiencing and understand what to ask for, so you walk into your appointment prepared rather than guessing.
Last reviewed for medical accuracy: 09/17/2026
Clostridioides difficile (C. diff) is a bacterium that can cause diarrhea and more serious intestinal conditions. If your stool appearance has changed—becoming loose, watery, foul-smelling or containing mucus—you may wonder whether you need testing for C. diff. This guide will explain when and how to get tested, what to expect from the lab, and next steps.
C. diff produces toxins that irritate the colon lining. Typical stool changes include:
These signs don’t always mean C. diff, but they suggest you should seek medical advice—especially if you’ve recently taken antibiotics or spent time in a healthcare setting.
You may consider C. diff testing if all of the following apply:
Risk factors that raise suspicion:
If you’re unsure whether your symptoms meet these criteria, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help you decide whether to seek immediate care.
Speak with a Healthcare Provider
Sample Collection
Testing Methods
Modern laboratories use one or more of the following tests:
Glutamate dehydrogenase (GDH) antigen test
• Screens for the C. diff organism.
• Highly sensitive but not specific for toxin-producing strains.
Toxin enzyme immunoassay (EIA)
• Detects toxins A and B directly in stool.
• Quick (results in hours), but less sensitive than molecular tests.
Nucleic acid amplification test (NAAT)/PCR
• Detects toxin-producing genes.
• High sensitivity and specificity.
Two-step or three-step algorithms
• Combines GDH + toxin EIA, with PCR confirmation for discordant results.
Where to Get Tested
Turnaround Time
Your healthcare provider will interpret results alongside your clinical presentation. A positive result in someone without symptoms may represent colonization rather than active disease; treatment isn’t always required in that setting.
If your test is positive, your doctor may recommend:
If your test is negative but diarrhea persists, your provider may:
Contact your doctor or go to the emergency department if you experience:
These could signal complications requiring urgent care.
C. diff spores can survive on surfaces for months. To reduce spread:
Recognizing suspicious stool appearance and acting promptly can help your healthcare team diagnose or rule out C. diff quickly. Early testing and appropriate treatment reduce the risk of complications.
If you’re uncertain about your symptoms or whether to get tested, try a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a helpful way to clarify your next steps before you see a provider.
Above all, speak to a doctor about any serious or life-threatening concerns. Prompt medical evaluation ensures you receive the right tests and care.
(References)
* Hooker M. Clostridium difficile. Clin J Oncol Nurs. 2007 Dec;11(6):801-4. doi: 10.1188/07.CJON.801-804. PMID: 18063537.
* Wiener-Well Y, Kaloti S, Hadas-Halpern I, Munter G, Yinnon AM. Ultrasound diagnosis of Clostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):1975-8. doi: 10.1007/s10096-015-2439-1. Epub 2015 Jul 15. PMID: 26173691.
* Brumbaugh DE, De Zoeten EF, Pyo-Twist A, Fidanza S, Hughes S, Dolan SA, Child J, Dominguez SR. An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive. J Pediatr. 2018 Mar;194:123-127.e1. doi: 10.1016/j.jpeds.2017.10.016. Epub 2017 Dec 1. PMID: 29198534.
* Sambri V, Gateau C, Zannoli S, Dirani G, Couturier J, Op den Buijs I, Roymans R, Hallet E, Arnold M, Zumoberhaus A, Steiner S, van de Bovenkamp J, Altwegg M, Berlinger L, Barbut F, revogene C. Difficile study group. Diagnosing Clostridioides difficile infections with molecular diagnostics: multicenter evaluation of revogene C. difficile assay. Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1169-1175. doi: 10.1007/s10096-020-03829-4. Epub 2020 Feb 15. PMID: 32062723; PMCID: PMC7225180.
* Thanissery R, McLaren MR, Rivera A, Reed AD, Betrapally NS, Burdette T, Winston JA, Jacob M, Callahan BJ, Theriot CM. Clostridioides difficile carriage in animals and the associated changes in the host fecal microbiota. Anaerobe. 2020 Dec;66:102279. doi: 10.1016/j.anaerobe.2020.102279. Epub 2020 Oct 3. PMID: 33022384; PMCID: PMC10760528.
* Lloyd CD, Shah-Gandhi B, Parsons BD, Morin SBN, Du T, Golding GR, Chui L. Direct Clostridioides difficile ribotyping from stool using capillary electrophoresis. Diagn Microbiol Infect Dis. 2021 Mar;99(3):115259. doi: 10.1016/j.diagmicrobio.2020.115259. Epub 2020 Nov 4. PMID: 33217718.
* Camilleri M. When and What to Test for Diarrhea: Focus on Stool Testing. Am J Gastroenterol. 2025 Apr 1;120(4):778-784. doi: 10.14309/ajg.0000000000003175. Epub 2024 Dec 6. PMID: 39480027.
* Eng L, Alene KA, Collins DA, Lim SC, Srey V, Chea C, Yohn S, Leng S, Clements ACA, Riley TV. Clostridioides (Clostridium) difficile in hospitalised children in Cambodia. Anaerobe. 2025 Jun;93:102959. doi: 10.1016/j.anaerobe.2025.102959. Epub 2025 Apr 15. PMID: 40245978.
* Daneri L, Urbano A, Escudero-Sánchez R, Halperin AV, Moreno-Blanco A, Corbacho MD, Suárez-Carantoña C, Rodríguez-Jiménez C, Serrano-Villar S, Campo RD, Cobo J. Lyophilised fecal microbiota transfer in capsules for recurrent Clostridioides difficile infection. Int J Antimicrob Agents. 2025 Oct;66(4):107561. doi: 10.1016/j.ijantimicag.2025.107561. Epub 2025 Jul 1. PMID: 40609706.
* Kelly CR, Feuerstadt P. Diagnosis and Management of Clostridioides difficile. Am J Gastroenterol. 2026 Mar 1;121(3):628-634. doi: 10.14309/ajg.0000000000003844. Epub 2025 Nov 17. PMID: 41247039.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.